Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of kinase inhibitors for cancer treatment. Exhibits activity in modulating signaling pathways involved in tumor growth and proliferation. Also employed in research settings to design compounds with improved metabolic stability and target selectivity due to the presence of trifluoromethyl and methoxy groups that influence lipophilicity and binding affinity.